Warren A Thompson, MD | |
160 Healthwest Dr, Dothan, AL 36303-1996 | |
(334) 712-1700 | |
(334) 699-1715 |
Full Name | Warren A Thompson |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 25 Years |
Location | 160 Healthwest Dr, Dothan, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962484790 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 00025149 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Andalusia Eye Clinic Llc | 1557386778 | 4 |
Retina Associates Of Alabama Inc | 0941247274 | 2 |
News Archive
Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.
Researchers have identified a group of anti-inflammatory compounds in the bark of the Scotch pine - widely used for Christmas trees - that they say could be developed into food supplements or drugs for treating arthritis and pain.
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
In 2009 a student research project investigating a low frequency therapy for temporary tinnitus was joint runner-up in the 2009 BT Young Scientist and Technology Exhibition, held in Dublin, Ireland. The student research project which has now evolved into a web-based company, Restored Hearing (www.restoredhearing.ie) was one of the companies which showcased recently at the 2010 exhibition.
› Verified 8 days ago
Entity Name | Retina Associates Of Alabama Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124042601 PECOS PAC ID: 0941247274 Enrollment ID: O20050408000494 |
News Archive
Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.
Researchers have identified a group of anti-inflammatory compounds in the bark of the Scotch pine - widely used for Christmas trees - that they say could be developed into food supplements or drugs for treating arthritis and pain.
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
In 2009 a student research project investigating a low frequency therapy for temporary tinnitus was joint runner-up in the 2009 BT Young Scientist and Technology Exhibition, held in Dublin, Ireland. The student research project which has now evolved into a web-based company, Restored Hearing (www.restoredhearing.ie) was one of the companies which showcased recently at the 2010 exhibition.
› Verified 8 days ago
Entity Name | Andalusia Eye Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629133111 PECOS PAC ID: 1557386778 Enrollment ID: O20051006000899 |
News Archive
Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.
Researchers have identified a group of anti-inflammatory compounds in the bark of the Scotch pine - widely used for Christmas trees - that they say could be developed into food supplements or drugs for treating arthritis and pain.
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
In 2009 a student research project investigating a low frequency therapy for temporary tinnitus was joint runner-up in the 2009 BT Young Scientist and Technology Exhibition, held in Dublin, Ireland. The student research project which has now evolved into a web-based company, Restored Hearing (www.restoredhearing.ie) was one of the companies which showcased recently at the 2010 exhibition.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Warren A Thompson, MD 160 Healthwest Dr, Dothan, AL 36303-1996 Ph: (334) 712-1700 | Warren A Thompson, MD 160 Healthwest Dr, Dothan, AL 36303-1996 Ph: (334) 712-1700 |
News Archive
Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.
Researchers have identified a group of anti-inflammatory compounds in the bark of the Scotch pine - widely used for Christmas trees - that they say could be developed into food supplements or drugs for treating arthritis and pain.
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
In 2009 a student research project investigating a low frequency therapy for temporary tinnitus was joint runner-up in the 2009 BT Young Scientist and Technology Exhibition, held in Dublin, Ireland. The student research project which has now evolved into a web-based company, Restored Hearing (www.restoredhearing.ie) was one of the companies which showcased recently at the 2010 exhibition.
› Verified 8 days ago
Dr. Aric J Aldridge, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1450 Ross Clark Cir Ste 100, Dothan, AL 36301 Phone: 334-479-0043 Fax: 334-479-0048 | |
Mr. Jean Guy Fortin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Circle, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Ronald P. Swendris, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Harsha A. Sen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
William Timothy Gannon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2664 Hartford Hwy, Dothan, AL 36305 Phone: 334-699-2244 Fax: 334-699-2245 | |
Dr. Jorge L Arango, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 Healthwest Dr, Dothan, AL 36303 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Andrew F Dannemann, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1909 Honeysuckle Rd, Suite 2, Dothan, AL 36305 Phone: 334-699-7100 Fax: 334-699-7410 |